外来がん化学療法登録レジメン大腸癌 Aflibercept+FOLFIRI BEV+FOLFIRI (5-FU+l-LV+CPT-11) BEV+FOLFOXIRI (5-FU+l-LV+L-OHP+CPT-11) BEV+mFOLFOX6 (5-FU+l-LV+L-OHP) BEV+SOX (S-1+L-OHP) BEV+TAS-102 BEV+XELOX (Capecitabine+L-OHP) Cetuximab+Encorafenib Cetuximab+Encorafenib+Binimetinib Cetuximab+FOLFIRI (5-FU+l-LV+CPT-11) FOLFIRI (5-FU+l-LV+CPT-11) Ipilimumab+Nivolumab (MSI-High) mFOLFOX6 (5-FU+l-LV+L-OHP) Nivolumab (240mg) Nivolumab (480mg) Panitumumab Panitumumab+Bi-weekly CPT-11 Panitumumab+FOLFIRI Panitumumab+mFOLFOX6 (5-FU+l-LV+L-OHP) SIR (S-1+CPT-11) XELOX (Capecitabine+L-OHP)
